Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2026)
Treace Medical Concepts (TMCI) posted Amortizatization of Intangibles of -$5000.0 for Q1 2026, down 225.0% on a QoQ basis from $4000.0 in Q4 2025, and down 106.49% year-over-year from $77000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Treace Medical Concepts' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at -$5000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 106.49% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41000.0 (down 95.38% YoY) and the FY2025 annual result came in at $123000.0, down 89.26% from the prior year.
- Amortizatization of Intangibles was -$5000.0 for Q1 2026 at Treace Medical Concepts, down from $4000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $375000.0 in Q4 2023 and bottomed at -$5000.0 in Q1 2026.
- A 5-year average of $199642.9 and a median of $230000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 197.62% — and 2026, when it slumped 106.49%.
- Treace Medical Concepts' Amortizatization of Intangibles stood at $126000.0 in 2022, then surged by 197.62% to $375000.0 in 2023, then slumped by 39.47% to $227000.0 in 2024, then sank by 98.24% to $4000.0 in 2025, then tumbled by 225.0% to -$5000.0 in 2026.
- Business Quant data shows TMCI's Amortizatization of Intangibles at -$5000.0 in Q1 2026, $4000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 375,000.00 |
| Dec 31, 2023 | 375,000.00 |